1. Home
  2. FEMY vs CLIR Comparison

FEMY vs CLIR Comparison

Compare FEMY & CLIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEMY
  • CLIR
  • Stock Information
  • Founded
  • FEMY 2004
  • CLIR 2008
  • Country
  • FEMY United States
  • CLIR United States
  • Employees
  • FEMY N/A
  • CLIR N/A
  • Industry
  • FEMY Medical/Dental Instruments
  • CLIR Industrial Machinery/Components
  • Sector
  • FEMY Health Care
  • CLIR Industrials
  • Exchange
  • FEMY Nasdaq
  • CLIR Nasdaq
  • Market Cap
  • FEMY 29.9M
  • CLIR 27.9M
  • IPO Year
  • FEMY 2021
  • CLIR 2012
  • Fundamental
  • Price
  • FEMY $0.87
  • CLIR $0.58
  • Analyst Decision
  • FEMY Strong Buy
  • CLIR Strong Buy
  • Analyst Count
  • FEMY 3
  • CLIR 1
  • Target Price
  • FEMY $8.67
  • CLIR $2.00
  • AVG Volume (30 Days)
  • FEMY 274.9K
  • CLIR 68.7K
  • Earning Date
  • FEMY 08-07-2025
  • CLIR 08-13-2025
  • Dividend Yield
  • FEMY N/A
  • CLIR N/A
  • EPS Growth
  • FEMY N/A
  • CLIR N/A
  • EPS
  • FEMY N/A
  • CLIR N/A
  • Revenue
  • FEMY $1,699,232.00
  • CLIR $2,895,000.00
  • Revenue This Year
  • FEMY $283.83
  • CLIR $27.61
  • Revenue Next Year
  • FEMY $161.03
  • CLIR $116.19
  • P/E Ratio
  • FEMY N/A
  • CLIR N/A
  • Revenue Growth
  • FEMY 61.97
  • CLIR 10.88
  • 52 Week Low
  • FEMY $0.69
  • CLIR $0.46
  • 52 Week High
  • FEMY $1.80
  • CLIR $1.72
  • Technical
  • Relative Strength Index (RSI)
  • FEMY 47.01
  • CLIR 53.43
  • Support Level
  • FEMY $0.91
  • CLIR $0.50
  • Resistance Level
  • FEMY $0.99
  • CLIR $0.60
  • Average True Range (ATR)
  • FEMY 0.04
  • CLIR 0.05
  • MACD
  • FEMY 0.00
  • CLIR 0.00
  • Stochastic Oscillator
  • FEMY 22.33
  • CLIR 64.57

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About CLIR ClearSign Technologies Corporation (DE)

ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.

Share on Social Networks: